Crucial breakthroughs in the treatment of many common diseases such as diabetes and Parkinson’s could be achieved by harnessing a powerful scientific approach called systems biology, according to leading scientists from across Europe. In a Science Policy Briefing released today by the European... [more]
Often experiments are needed to make scientific progress, but sometimes the answers lie in data already collected, requiring new analysis tools to unlock the secrets. This applies to infectious disease transmission, main topic of a recent workshop organised by the European Science Foundation (ESF),... [more]
The dream of designer drugs highly specific in action with zero side effects has come closer by combining atomic level computer prediction with natural selection in the laboratory. Following the 2008’s first design of an artificial enzyme for catalysing a chemical reaction, there is increased... [more]
Human and veterinary medicine could receive a big boost through the use of larger animals, especially pigs and dogs, in research, with Europe at the forefront. There is the prospect of bringing drugs to the market more quickly at less cost, as well as accelerating progress in other forms of... [more]
More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines. The discovery of penicillin to treat bacterial infections, along with the development of vaccines for previously incurable virus diseases such as polio and... [more]
A potent combination of powerful new analysis methods and abundant data from genomics projects is carrying microbiology forward into a new era. Bacteria in particular are shedding light on fundamental molecular and signalling processes of interest not just within microbiology, but across the whole... [more]
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. This in turn provides clues to more effective therapies for both... [more]
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. One reason is that medical... [more]
The question whether a common European position on advance directives, or “living wills” is ethically required and practically feasible was discussed at a recent workshop organised by the European Science Foundation (ESF). Just as a conventional will allows people to specify how they would like... [more]
Researchers are on the verge of unleashing the power of the element boron in a new generation of drugs and therapies, as decades of research begins to bear fruit. Boron has to date far been one of biology’s best kept secrets, but is now attracting fast growing research interest and investment from... [more]